ci 994 has been researched along with Leukemia L 1210 in 1 studies
tacedinaline: oral cytostatic drug with impressive differential activity against leukemic cells & normal stem-cells
tacedinaline : A benzamide obtained by formal condensation of the carboxy group of 4-acetamidobenzoic acid with one of the amino groups of 1,2-phenylenediamine. An oral cytostatic drug with impressive differential activity against leukemic cells and normal stem-cells. Also used in combination therapy for selected tumors including non-smoll cell lung, pancreatic, breast, and colorectal cancers.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| LoRusso, PM | 1 |
| Demchik, L | 1 |
| Foster, B | 1 |
| Knight, J | 1 |
| Bissery, MC | 1 |
| Polin, LM | 1 |
| Leopold, WR | 1 |
| Corbett, TH | 1 |
1 other study available for ci 994 and Leukemia L 1210
| Article | Year |
|---|---|
Preclinical antitumor activity of CI-994.
Topics: Animals; Antineoplastic Agents; Benzamides; Drug Administration Schedule; Drug Screening Assays, Ant | 1996 |